Related references
Note: Only part of the references are listed.Distinct pathways of antigen uptake and intracellular routing in CD4 and CD8 T cell activation
Sven Burgdorf et al.
SCIENCE (2007)
Development of lactococcal GEM-based pneumococcal vaccines
Sandrine A. L. Audouy et al.
VACCINE (2007)
N-Trimethyl chitosan (TMC) nanoparticles loaded with influenza subunit antigen for intranasal vaccination:: Biological properties and immunogenicity in a mouse model
Maryam Amidi et al.
VACCINE (2007)
Nanoparticulate systems for nasal delivery of drugs: A real improvement over simple systems?
Lisbeth Illum
JOURNAL OF PHARMACEUTICAL SCIENCES (2007)
Nanoparticles based on N-trimethylchitosan: Evaluation of absorption properties using in vitro (Caco-2 cells) and ex vivo (excised rat jejunum) models
Giuseppina Sandri et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2007)
A bacterial carbohydrate links innate and adaptive responses through Toll-like receptor 2
Qun Wang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Uptake of microparticles into the epithelium of human nasopharyngeal lymphoid tissue
Yoshinori Fujimura et al.
MEDICAL MOLECULAR MORPHOLOGY (2006)
Enhancement of CD8+ T cell immunity in the lung by CpG oligodeoxynucleotides increases protective efficacy of a modified vaccinia ankara vaccine against lethal poxvirus infection even in a CD4-deficient host
Igor M. Belyakov et al.
JOURNAL OF IMMUNOLOGY (2006)
Identification of cell adhesion molecules in the human follicle-associated epithelium that improve nanoparticle uptake into the Peyer's patches
Elisabet Gullberg et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Nasal immunization with a dual antigen anthrax vaccine induced strong mucosal and systemic immune responses against toxins and bacilli
Brian R. Sloat et al.
VACCINE (2006)
Induction of systemic and mucosal immune responses by intranasal administration of alginate microspheres encapsulated with tetanus toxoid and CpG-ODN
Mohsen Tafaghodi et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2006)
Nasal immunization with anthrax protective antigen protein adjuvanted with polyriboinosinic-polyribocytidylic acid induced strong mucosal and systemic immunities
Brian R. Sloat et al.
PHARMACEUTICAL RESEARCH (2006)
In vivo induction of mucosal immune responses by intranasal administration of chitosan microspheres containing Bordetella bronchiseptica DNT
Mi Lan Kang et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2006)
Strong systemic and mucosal immune responses to surface-modified PLGA microspheres containing recombinant Hepatitis B antigen administered intranasally
K. S. Jaganathan et al.
VACCINE (2006)
Mucosal adjuvant properties of the Shigella invasin complex
RW Kaminski et al.
INFECTION AND IMMUNITY (2006)
A new intranasal influenza vaccine based on a novel polycationic lipid - ceramide carbamoyl-spermine (CCS) - I. Immunogenicity and efficacy studies in mice
Aviva Joseph et al.
VACCINE (2006)
Biosafety evaluation of recombinant live oral bacterial vaccines in the context of European regulation
Didier Favre et al.
VACCINE (2006)
Pharmaceutical and immunological evaluation of a single-dose hepatitis B vaccine using PLGA microspheres
L Feng et al.
JOURNAL OF CONTROLLED RELEASE (2006)
Mutant Escherichia coli enterotoxin as a mucosal adjuvant induces specific Th1 responses of CD4+ and CD8+ T cells to nasal killed-bacillus calmette-guerin in mice
H Takahashi et al.
VACCINE (2006)
Needle-free vaccine delivery
EL Giudice et al.
ADVANCED DRUG DELIVERY REVIEWS (2006)
Toll-dependent selection of microbial antigens for presentation by dendritic cells
JM Blander et al.
NATURE (2006)
Induction of systemic and mucosal immune response and decrease in Streptococcus pneumoniae colonization by nasal inoculation of mice with recombinant lactic acid bacteria expressing pneumococcal surface antigen A
Maria Leonor Sarno Oliveira et al.
MICROBES AND INFECTION (2006)
Enhancement of intranasal vaccination in mice with deglycosylated chain A ricin by LTR72, a novel mucosal adjuvant
M Kende et al.
VACCINE (2006)
Nasal vaccination with CpG oligodeoxynucleotide induces protective immunity against nontypeable Haemophilus influenzae in the nasopharynx
N Abe et al.
LARYNGOSCOPE (2006)
Safety and efficacy of nasal application of CpG oligodeoxynucleotide as a mucosal adjuvant
S Kodama et al.
LARYNGOSCOPE (2006)
Microbial pattern recognition receptors mediate M-cell uptake of a gram-negative bacterium
P Tyrer et al.
INFECTION AND IMMUNITY (2006)
A bacterial flagellin, Vibrio vulnificus FlaB, has a strong mucosal adjuvant activity to induce protective immunity
SE Lee et al.
INFECTION AND IMMUNITY (2006)
Pathogen recognition and development of particulate vaccines: Does size matter?
Sue D. Xiang et al.
METHODS (2006)
Enhanced and prolonged cross-presentation following endosomal escape of exogenous antigens encapsulated in biodegradable nanoparticles
H Shen et al.
IMMUNOLOGY (2006)
Immunisation status of children in Germany: temporal trends and regional differences
H Kalies et al.
EUROPEAN JOURNAL OF PEDIATRICS (2006)
In vivo targeting of dendritic cells for activation of cellular immunity using vaccine carriers based on pH-responsive microparticles
YJ Kwon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Comparison of the mucoadhesive properties of various polymers
V Grabovac et al.
ADVANCED DRUG DELIVERY REVIEWS (2005)
The basics and underlying mechanisms of mucoadhesion
JD Smart
ADVANCED DRUG DELIVERY REVIEWS (2005)
Nasal mucoadhesive drug delivery: Background, applications, trends and future perspectives
MI Ugwoke et al.
ADVANCED DRUG DELIVERY REVIEWS (2005)
Influenza vaccination coverage rates in five European countries -: A population-based cross-sectional analysis of two consecutive influenza seasons
TD Szucs et al.
VACCINE (2005)
Enterotoxin-based mucosal adjuvants alter antigen trafficking and induce inflammatory responses in the nasal tract
FW van Ginkel et al.
INFECTION AND IMMUNITY (2005)
Poly (lactide-co-glycolide) particles of different physicochemical properties and their uptake by Peyer's patches in mice
M Shakweh et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2005)
Effective nasal influenza vaccine delivery using chitosan
RC Read et al.
VACCINE (2005)
Enhanced antigen presentation and immunostimulation of dendritic cells using acid-degradable cationic nanoparticles
YJ Kwon et al.
JOURNAL OF CONTROLLED RELEASE (2005)
Peptide-loaded chimeric influenza virosomes for efficient in vivo induction of cytotoxic T cells
M Amacker et al.
INTERNATIONAL IMMUNOLOGY (2005)
Transgene vaccination using Ulex europaeus agglutinin I (UEA-1) for targeted mucosal immunization against HIV-1 envelope
XH Wang et al.
VACCINE (2005)
Negative attitude of highly educated parents and health care workers towards future vaccinations in the Dutch childhood vaccination program
E Hak et al.
VACCINE (2005)
Intermediate filaments and vesicular membrane traffic: The odd couple's first dance?
ML Styers et al.
TRAFFIC (2005)
Differential binding of Escherichia coli enterotoxins LT-IIa and LT-IIb and of cholera toxin elicits differences in apoptosis, proliferation, and activation of lymphoid cells
S Arce et al.
INFECTION AND IMMUNITY (2005)
Type I IFN is a powerful mucosal adjuvant for a selective intranasal vaccination against influenza virus in mice and affects antigen capture at mucosal level
L Bracci et al.
VACCINE (2005)
ISCOM™-based vaccines:: The second decade
MT Sanders et al.
IMMUNOLOGY AND CELL BIOLOGY (2005)
Targeting the innate immune response with improved vaccine adjuvants
A Pashine et al.
NATURE MEDICINE (2005)
Nanoparticles as carriers for nasal vaccine delivery
M Köping-Höggård et al.
EXPERT REVIEW OF VACCINES (2005)
PLA-PEG particles as nasal protein carriers:: the influence of the particle size
A Vila et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2005)
Synthetic double-stranded RNA poly(I:C) combined with mucosal vaccine protects against influenza virus infection
T Ichinohe et al.
JOURNAL OF VIROLOGY (2005)
Intranasal CpG-Oligodeoxynucleotide is a potent adjuvant of vaccine against Helicobacter pylori, and t helper 1 type response and interferon-γ correlate with the protection
T Shi et al.
HELICOBACTER (2005)
Virosome-mediated delivery of protein antigens in vivo: efficient induction of class I MHC-restricted cytotoxic T lymphocyte activity
L Bungener et al.
VACCINE (2005)
Directed antigen presentation using polymeric microparticulate carriers degradable at lysosomal pH for controlled immune responses
Young Jik Kwon et al.
MOLECULAR PHARMACEUTICS (2005)
Virosomes for antigen and DNA delivery
T Daemen et al.
ADVANCED DRUG DELIVERY REVIEWS (2005)
ISCOMATRIX® adjuvant for antigen delivery
MJ Pearse et al.
ADVANCED DRUG DELIVERY REVIEWS (2005)
Immunity in response to particulate antigen-delivery systems
T Storni et al.
ADVANCED DRUG DELIVERY REVIEWS (2005)
Targeted vaccine adjuvants based on modified cholera toxin
N Lycke
CURRENT MOLECULAR MEDICINE (2005)
Access of soluble antigens to the endoplasmic reticulum can explain cross-presentation by dendritic cells
AL Ackerman et al.
NATURE IMMUNOLOGY (2005)
Bone resorption in infants of diabetic mothers
A Lapillonne et al.
ACTA PAEDIATRICA (2005)
Vaccination coverage among adolescents in certain provinces of Greece
M Bitsori et al.
ACTA PAEDIATRICA (2005)
Novel chitosan particles and chitosan-coated emulsions inducing immune response via intranasal vaccine delivery
T Nagamoto et al.
PHARMACEUTICAL RESEARCH (2004)
Cutting edge:: Activation of toll-like receptor 2 induces a Th2 immune response and promotes experimental asthma
V Redecke et al.
JOURNAL OF IMMUNOLOGY (2004)
Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland
M Mutsch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Cutting edge: Dendritic cells copulsed with microbial and helminth antigens undergo modified maturation, segregate the antigens to distinct intracellular compartments, and concurrently induce microbe-specific Th1 and helminth-specific Th2 responses
L Cervi et al.
JOURNAL OF IMMUNOLOGY (2004)
Influenza virosomes enhance class I restricted CTL induction through CD4+T cell activation
R Schumacher et al.
VACCINE (2004)
Toll-like receptor control of the adaptive immune responses
A Iwasaki et al.
NATURE IMMUNOLOGY (2004)
Intranasal immunisation of mice with liposomes containing recombinant meningococcal OpaB and OpaJ proteins
MI de Jonge et al.
VACCINE (2004)
Association of antigens to ISCOMATRIX™ adjuvant using metal chelation leads to improved CTL responses
J Malliaros et al.
VACCINE (2004)
A comparative evaluation of nasal and parenteral vaccine adjuvants to elicit systemic and mucosal HIV-1 peptide-specific humoral immune responses in cynomolgus macaques
MA Egan et al.
VACCINE (2004)
ISCOMATRIX™ adjuvant:: an adjuvant suitable for use in anticancer vaccines
TJ Stewart et al.
VACCINE (2004)
Mucosal immunization with purified flagellin from Salmonella induces systemic and mucosal immune responses in C3H/HeJ mice
L Strindelius et al.
VACCINE (2004)
Mucosal vaccination against serogroup B meningococci:: Induction of bactericidal antibodies and cellular immunity following intranasal immunization with NadA of Neisseria meningitidis and mutants of Escherichia coli heat-labile enterotoxin
F Bowe et al.
INFECTION AND IMMUNITY (2004)
The Mycoplasma-derived macrophage-activating 2-kilodalton lipopeptide triggers global immune activation on nasal mucosa-associated lymphoid tissues
F Rharbaoui et al.
INFECTION AND IMMUNITY (2004)
Novel adjuvant based on a proteoliposome-derived cochleate structure containing native lipopolysaccharide as a pathogen-associated molecular pattern
O Pérez et al.
IMMUNOLOGY AND CELL BIOLOGY (2004)
The role of M cells of human nasopharyngeal lymphoid tissue in influenza virus sampling
Y Fujimura et al.
VIRCHOWS ARCHIV (2004)
Cellular mechanisms governing cross-presentation of exogenous antigens
AL Ackerman et al.
NATURE IMMUNOLOGY (2004)
Pluronic® F127-based systemic vaccine delivery systems
CM Coeshott et al.
VACCINE (2004)
Virosomes as new carrier system for cancer vaccines
R Schwaninger et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2004)
Strong local and systemic protective immunity induced in the ferret model by an intranasal virosome-formulated influenza subunit vaccine
R Lambkin et al.
VACCINE (2004)
Glycol chitosan improves the efficacy of intranasally administrated replication defective human adenovirus type 5 expressing glycoprotein D of bovine herpesvirus 1
S Gogev et al.
VACCINE (2004)
Cutting edge: Different toll-like receptor agonists instruct dendritic cells to induce distinct th responses via differential modulation of extracellular signal-regulated kinase-mitogen-activated protein kinase and c-fos
S Agrawal et al.
JOURNAL OF IMMUNOLOGY (2003)
Mucosal antibody response induced with a nasal virosome-based influenza vaccine
P Durrer et al.
VACCINE (2003)
New generation of mucosal adjuvants for the induction of protective immunity
Y Yuki et al.
REVIEWS IN MEDICAL VIROLOGY (2003)
Membranous cells in nasal-associated lymphoid tissue: A portal of entry for the respiratory mucosal pathogen group A streptococcus
HS Park et al.
JOURNAL OF IMMUNOLOGY (2003)
Immunogenicity of bovine parainfluenza type 3 virus proteins encapsulated in nanoparticle vaccines, following intranasal administration to mice
MJ Shephard et al.
RESEARCH IN VETERINARY SCIENCE (2003)
A modified cholera holotoxin CT-E29H enhances systemic and mucosal immune responses to recombinant Norwalk virus-virus like particle vaccine
SB Periwal et al.
VACCINE (2003)
Smallpox vaccine: problems and prospects
GA Poland et al.
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2003)
Pattern recognition receptors: Doubling up for the innate immune response
S Gordon
CELL (2002)
Intranasal immunization with influenza vaccine and a detoxified mutant of heat labile enterotoxin from Escherichia coli (LTK63)
S Pine et al.
JOURNAL OF CONTROLLED RELEASE (2002)
Preclinical development of an adjuvant-free peptide vaccine with activity against CMV pp65 in HLA transgenic mice
C La Rosa et al.
BLOOD (2002)
Influenza virosomes are an efficient delivery system for respiratory syncytial virus-F antigen inducing humoral and cell-mediated immunity
MG Cusi et al.
VACCINE (2002)
Liposomal immunostimulatory DNA sequence (ISS-ODN): an efficient parenteral and mucosal adjuvant for influenza and hepatitis B vaccines
A Joseph et al.
VACCINE (2002)
Intranasal administration of a synthetic peptide vaccine encapsulated in liposome together with an anti-CD40 antibody induces protective immunity against influenza A virus in mice
A Ninomiya et al.
VACCINE (2002)
Type I IFN as a natural adjuvant for a protective immune response: Lessons from the influenza vaccine model
E Proietti et al.
JOURNAL OF IMMUNOLOGY (2002)
Immunogenicity of anti-Haemophilus influenzae type b CRM197 conjugate following mucosal vaccination with oligodeoxynucleotide containing immunostimulatory sequences as adjuvant
S Mariotti et al.
VACCINE (2002)
Toll-like receptor 4 is required for optimal development of Th2 immune responses: Role of dendritic cells
K Dabbagh et al.
JOURNAL OF IMMUNOLOGY (2002)
Nasal-associated lymphoid tissue is a mucosal inductive site for virus-specific humoral and cellular immune responses
AW Zuercher et al.
JOURNAL OF IMMUNOLOGY (2002)
Toll-like receptors as adjuvant receptors
T Kaisho et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2002)
Design of biodegradable particles for protein delivery
A Vila et al.
JOURNAL OF CONTROLLED RELEASE (2002)
Effect of neuraminidase on receptor-mediated adherence of Streptococcus pneumoniae to chinchilla tracheal epithelium
HH Tong et al.
ACTA OTO-LARYNGOLOGICA (2002)
An open-label comparison of the immunogenicity and tolerability of intranasal and intramuscular formulations of virosomal influenza vaccine in healthy adults
MDB di Valserra et al.
CLINICAL THERAPEUTICS (2002)
Targeting vaccines to dendritic cells
C Foged et al.
PHARMACEUTICAL RESEARCH (2002)
Highly purified mutant E112K of cholera toxin elicits protective lung mucosal immunity to diphtheria toxin
M Ohmura et al.
VACCINE (2001)
Isotype-specific selection of high affinity memory B cells in nasal-associated lymphoid tissue
M Shimoda et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Lipopolysaccharides from distinct pathogens induce different classes of immune responses in vivo
B Pulendran et al.
JOURNAL OF IMMUNOLOGY (2001)
Review of intranasal influenza vaccine
R Glueck
ADVANCED DRUG DELIVERY REVIEWS (2001)
The response to plasmid DNA-virosome vaccination: a role for circulating antibodies?
MG Cusi
TRENDS IN IMMUNOLOGY (2001)
Improvement in the mucoadhesive properties of alginate by the covalent attachment of cysteine
A Bernkop-Schnürch et al.
JOURNAL OF CONTROLLED RELEASE (2001)
Clearance characteristics of chitosan based formulations in the sheep nasal cavity
RJ Soane et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2001)
Flagellin expressed by live Salmonella vaccine strains induces distinct antibody responses following delivery via systemic or mucosal immunization routes
ME Sbrogio-Almeida et al.
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2001)
Genetically manipulated bacterial toxin as a new generation mucosal adjuvant
M Yamamoto et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2001)
Tetanus toroid loaded nanoparticles from sulfobutylated poly(vinyl alcohol)-graft-poly(lactide-co-glycolide): Evaluation of antibody response after oral and nasal application in mice
T Jung et al.
PHARMACEUTICAL RESEARCH (2001)
A novel bioadhesive intranasal delivery system for inactivated influenza vaccines
M Singh et al.
JOURNAL OF CONTROLLED RELEASE (2001)
Transport of nanoparticles across the rat nasal mucosa
J Brooking et al.
JOURNAL OF DRUG TARGETING (2001)
A mucosal vaccine against diphtheria:: formulation of cross reacting material (CRM197) of diphtheria toxin with chitosan enhances local and systemic antibody and Th2 responses following nasal delivery
EA McNeela et al.
VACCINE (2000)
Modulation of innate and acquired immune responses by Escherichia coli heat-labile toxin:: Distinct pro- and anti-inflammatory effects of the nontoxic AB complex and the enzyme activity
EJ Ryan et al.
JOURNAL OF IMMUNOLOGY (2000)
Oral immunization with size-purified microsphere beads as a vehicle selectively induces systemic tolerance and sensitization
Y Matsunaga et al.
VACCINE (2000)
Lectin binding patterns in rat nasal-associated lymphoid tissue (NALT) and the influence of various types of lectin on particle uptake in NALT
S Takata et al.
ARCHIVES OF HISTOLOGY AND CYTOLOGY (2000)
Adjuvant activity of monophosphoryl lipid A for nasal and oral immunization with soluble or liposome-associated antigen
NK Childers et al.
INFECTION AND IMMUNITY (2000)
Enterotoxin adjuvants have direct effects on T cells and antigen-presenting cells that result in either interleukin-4-dependent or -independent immune responses
M Yamamoto et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
Immunopotentiating of mucosal and systemic antibody responses in mice by intranasal immunization with HLT-combined influenza virosomal vaccine
MG Cusi et al.
VACCINE (2000)
Evidence of M cells as portals of entry for antigens in the nasopharyngeal lymphoid tissue of humans
Y Fujimura
VIRCHOWS ARCHIV (2000)
Ultrastructural study on the follicle-associated epithelium of nasal-associated lymphoid tissue in specific pathogen-free (SPF) and conventional environment-adapted (SPF-CV) rats
KI Jeong et al.
JOURNAL OF ANATOMY (2000)
Intranasal immunization with liposome-formulated Yersinia pestis vaccine enhances mucosal immune responses
ME Baca-Estrada et al.
VACCINE (2000)
Share Paper
